Nevertheless, CPA4 was found to be a key regulator of cardiac hypertrophy through activating PI3K-AKT-mTOR signaling and may serve as a promising therapy target for hypertrophic cardiac diseases (23). Here, MTOR is linked to cardiac hypertrophy.